Oxford Science Enterprises (OSE)
Investor profile
Investment firm
Deals
6
distinct rounds
Companies
6
backed
Active span
2023–2026
4 yrs
Total round €
€142M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- AlbionVC1
- Apollo Health Ventures1
- Berkeley Skydeck1
- Cedars-Sinai Intellectual Property Co.1
- Creator Fund1
- Empirical Ventures1
- Habico Invest1
- Lansdowne Partners1
- Oxford Investment Consultants1
- Oxford Technology and Innovations EIS Fund (OTIF)1
- Oxford University Innovation Fund1
- Parkwalk Advisors1
- Partech Ventures1
- SBI Group1
- the family office of Danish pharmaceutical group Orifarm1
- University of Tokyo Edge Capital Partners (UTEC)1
- YZR Capital1
- Zero Carbon Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Oxford Quantum Circuits | UK | 1 | €91M |
| Prolific | UK | 1 | €29M |
| Scripta Therapeutics | UK | 1 | €10M |
| Caudal Energy | UK | 1 | €5.0M |
| Allos | UK | 1 | €4.3M |
| Neu Health | UK | 1 | €1.9M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Oxford Quantum Circuits | Series B | €91M | 2023-11 |
| Prolific | Series A | €29M | 2023-07 |
| Scripta Therapeutics | Seed | €10M | 2025-11 |
| Caudal Energy | Other | €5.0M | 2026-05 |
| Allos | Seed | €4.3M | 2026-01 |
| Neu Health | Other | €1.9M | 2025-01 |